Association between dermatologic adverse events and quality of life in lung cancer patients treated with epidermal growth factor receptor-tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Association between dermatologic adverse events and quality of life in lung cancer patients treated with epidermal growth factor receptor-tyrosine kinase inhibitors

Published:2022-09-03 Issue:11 Volume:30 Page:9211-9219
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Hsu Hui-Te,Yu Chu-Chun,Lee Yun-Hsiang,Chan Jui-Chun,Chu Chia-Yu^ORCID

Funder

National Taiwan University Hospital

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-022-07347-1.pdf

Reference27 articles.

1. Hsu WH, Yang JC, Mok TS, Loong HH (2018) Overview of current systemic management of EGFR-mutant NSCLC. Ann Oncol 29(suppl_1):i3–i9. https://doi.org/10.1093/annonc/mdx702

2. Mok TS, Wu YL, Ahn MJ, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA, Investigators A (2017) Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. N Engl J Med 376(7):629–640. https://doi.org/10.1056/NEJMoa1612674

3. Lacouture ME (2006) Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer 6(10):803–812. https://doi.org/10.1038/nrc1970

4. Kozuki T (2016) Skin problems and EGFR-tyrosine kinase inhibitor. Jpn J Clin Oncol 46(4):291–298. https://doi.org/10.1093/jjco/hyv207

5. Ding PN, Lord SJ, Gebski V, Links M, Bray V, Gralla RJ, Yang JC, Lee CK (2017) Risk of treatment-related toxicities from EGFR tyrosine kinase inhibitors: a meta-analysis of clinical trials of gefitinib, erlotinib, and afatinib in advanced EGFR-mutated non-small cell lung cancer. J Thorac Oncol 12(4):633–643. https://doi.org/10.1016/j.jtho.2016.11.2236

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics Analysis Based on Realistic Ingredients Combined with Molecular Docking and Molecular Dynamics Simulation to Explore the Mechanism of Jinbei Oral Liquid in the Therapy of Idiopathic Pulmonary Fibrosis;2024